We are live on ! Find out more
CRMD icon

CorMedix
CRMD

172 hedge funds and large institutions have $421M invested in CorMedix in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 63 increasing their positions, 35 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 14

187% more capital invested

Capital invested by funds: $146M → $421M (+$274M)

80% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 35

55% more call options, than puts

Call options by funds: $13M | Put options by funds: $8.42M

26% more funds holding

Funds holding: 137 → 172 (+35)

13.92% more ownership

Funds ownership: 36.45% → 50.37% (+14%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
172
Holders Change
+35
Holders Change %
+25.55%
% of All Funds
2.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
51
Increased
63
Reduced
35
Closed
14
Calls
$13M
Puts
$8.42M
Net Calls
+$4.63M
Net Calls Change
+$5.75M

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$25.9M
2
Citadel Advisors
Citadel Advisors
Florida
+$17.8M
3
N
Nuveen
North Carolina
+$13.2M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$8.28M
5
GCM
Ghisallo Capital Management
Massachusetts
+$8.28M

Top Sellers

Rank Fund Capital Flow
1
EIM
Elliott Investment Management
Florida
-$15.1M
2
UBS Group
UBS Group
Switzerland
-$3.61M
3
Millennium Management
Millennium Management
New York
-$3.48M
4
ECM
ExodusPoint Capital Management
New York
-$1.86M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swedbank
26
Swedbank
Sweden
$3.08M – – –
EGI
27
EAM Global Investors
California
$3.07M +$2.75M +249,343 New
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$2.71M -$119K -10,798 -5%
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
$2.65M +$1.01M +91,720 +74%
Bank of America
30
Bank of America
North Carolina
$2.62M +$1.92M +173,994 +448%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.6M +$747K +67,702 +47%
Goldman Sachs
32
Goldman Sachs
New York
$2.42M +$185K +16,803 +9%
Charles Schwab
33
Charles Schwab
California
$2.41M +$202K +18,267 +10%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$2.34M -$1.46M -132,499 -41%
UBS AM
35
UBS AM
Illinois
$2.34M +$929K +84,166 +80%
Voloridge Investment Management
36
Voloridge Investment Management
Florida
$2.32M +$2.08M +188,131 New
Ameriprise
37
Ameriprise
Minnesota
$2.19M +$688K +62,322 +54%
Invesco
38
Invesco
Georgia
$2.18M -$1.24M -112,165 -39%
ACM
39
ADAR1 Capital Management
Texas
$2.16M +$1.93M +175,000 New
Wellington Management Group
40
Wellington Management Group
Massachusetts
$2.11M +$79.1K +7,169 +4%
SPIA
41
Steward Partners Investment Advisory
New York
$2.04M +$65.4K +5,925 +4%
EI
42
EAM Investors
California
$1.95M +$1.75M +158,571 New
Renaissance Technologies
43
Renaissance Technologies
New York
$1.88M +$1.68M +152,200 New
Barclays
44
Barclays
United Kingdom
$1.79M +$637K +57,734 +66%
WWA
45
Wingate Wealth Advisors
Massachusetts
$1.6M +$38.9K +3,522 +3%
Swiss National Bank
46
Swiss National Bank
Switzerland
$1.45M – – –
Commonwealth Equity Services
47
Commonwealth Equity Services
Massachusetts
$1.39M -$12.3K -1,115 -1%
MCP
48
Militia Capital Partners
Nevada
$1.23M +$1.1M +100,000 New
AQR Capital Management
49
AQR Capital Management
Connecticut
$1.22M +$930K +84,204 +582%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$1.14M +$125K +11,340 +14%
1
2
3 4 5

CRMD Hedge Fund Activity: Q2 2025 in Review

172 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q2 2025, worth a combined $421M — up 187% from $146M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new CRMD positions and 14 closed out — a net gain of 37 holders — while 63 added to existing stakes and 35 trimmed.

The largest buyer was Marshall Wace, adding an estimated $25.9M. The largest seller was Elliott Investment Management, exiting entirely with an estimated $15.1M sold.

  • 172 institutional investors held CorMedix (CRMD) as of Q2 2025, up from 137 in Q1 2025.
  • Funds reported $421M of CorMedix stock for Q2 2025, up 187% quarter-over-quarter.
  • 51 funds opened new CorMedix positions in Q2 2025 and 14 closed out, a net change of +37 holders.
  • The largest CorMedix buyer in Q2 2025 was Marshall Wace, an estimated $25.9M added.
  • The largest CorMedix seller in Q2 2025 was Elliott Investment Management, an estimated $15.1M sold.

Based on aggregated 13F filings for Q2 2025.